Le Lézard
Classified in: Health, Business
Subject: SBS

VERTESS Posts Strong Q1 2024, Ranked #1 M&A Firm by Axial


FORT WORTH, Texas, May 9, 2024 /PRNewswire/ -- VERTESS (http://vertess.com), a leading healthcare mergers and acquisitions (M&A) advisory firm, was recently named the #1 lower middle market investment bank for Q1 2024 by Axial (http://axial.net), a private deal network serving professionals who own, advise, and invest in North American companies. The first quarter of 2024 saw 2,534 total sellside deals marketed on the Axial platform, which was an increase from the previous two quarters. In particular, healthcare was the industry with the highest pursuit rate on the platform. 

VERTESS also facilitated three transactions in Q1 2024.  MyDoc Urgent Care (http://mydocuc.com), a multi-location urgent care center based in Pennsylvania, was acquired by MyTown Health Partners (http://mytownhealthpartners.com), a comprehensive practice management services organization recently formed by Webster Equity Partners.  MyDoc Urgent Care provides urgent care, primary care, occupational medicine, workers comp, physicals, wellness and holistic medicine to local communities in Philadelphia.  VERTESS Managing Directors Anna Elliott and Blake Peart represented the sellers in the transaction. 

"We felt like the owners of myDoc became a part of our family during the process," stated Anna Elliott, who has over 20 years of M&A experience. "Our primary objective is to always meet the client needs for their future goals," added Blake Peart, a former executive with decades of operational experience in hospitals and ambulatory surgery centers (ASCs). "Their satisfaction is the top priority."

VERTESS Managing Director Dave Turgeon and Director Jack Turgeon led efforts on two significant transactions in the intellectual and developmental disability (I/DD) space.  Gold Medal Home Health (http://goldmedalhomehealth.com), an I/DD services provider based in New Jersey, was acquired by Abound Health (http://aboundhealth.com), a North Carolina-based leading provider dedicated to supporting individuals with diverse needs.  North Valley Developmental Services, Inc., a California I/DD company, was acquired by Merakey (http://merakey.org), a national provider of services for children, adolescents, and their families in areas of mental health and autism based in Pennsylvania. 

"Assisting companies who provide these valuable supports is an extremely rewarding process.  We know how important it is to establish the right partnership to keep critical services in place," commented Jack Turgeon. "We are extremely pleased to have facilitated these transitions."

For questions about VERTESS, please contact Vaughne Glennie at +1(520)395-0244 or [email protected]

SOURCE Vertess Healthcare Advisors


These press releases may also interest you

at 07:15
mBIOTA Labs, a medical food company revolutionizing oral nutrition through their proprietary palatable elemental diet, mBIOTA Elementaltm, today announced the initial study results of their first prospective clinical trial assessing the efficacy of...

at 07:05
Beaconcure Inc., a leader in AI-enabled clinical data validation and automation, announces a strategic partnership with Phastar Inc., a global specialist biometrics contract research organization (CRO), to enhance clinical review processes in...

at 07:05
BPGbio, a leading biology-first AI-powered biopharma that focuses on oncology, neurology, and rare diseases, announced today the publication of a significant, multi-year research effort titled "Identification and validation of N-acetylputrescine in...

at 07:05
Septerna, a biotechnology company discovering and advancing novel, oral small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced that the company will present the first preclinical data on the company's parathyroid...

at 07:00
In recognition of Clinical Trials Day, The Trial for #ClinicalEquality ?a longstanding and widely celebrated initiative from FCB Health New York, an IPG Health company ? continues the fight to increase equity in clinical trials with the next phase of...

at 07:00
The InterMed Group ("InterMed" or the "Company"), a leading provider of healthcare technology management services, proudly announces the appointment of Michael Koffler as its new Chief Executive Officer....



News published on and distributed by: